13F HOLDINGS REPORT
Cutter Capital Management, LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001214659-24-009296
Total Value
$259.3M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 446,900 | $24.2M | 9.34% |
| 2 | GILEAD SCIENCES INC | GILD | 265,436 | $19.4M | 7.50% |
| 3 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,135,710 | $16.0M | 6.18% |
| 4 | REGENERON PHARMACEUTICALS | REGN | 16,360 | $15.7M | 6.07% |
| 5 | BIOMARIN PHARMACEUTICAL INC | BMRN | 175,000 | $15.3M | 5.89% |
| 6 | IONIS PHARMACEUTICALS INC | IONS | 289,366 | $12.5M | 4.84% |
| 7 | ROYALTY PHARMA PLC | RPRX | 411,540 | $12.5M | 4.82% |
| 8 | SAREPTA THERAPEUTICS INC | SRPT | 94,379 | $12.2M | 4.71% |
| 9 | ACADIA PHARMACEUTICALS INC | ACAD | 658,409 | $12.2M | 4.69% |
| 10 | BIOGEN INC | BIIB | 52,000 | $11.2M | 4.32% |
| 11 | BIOCRYST PHARMACEUTICALS INC | BCRX | 2,105,459 | $10.7M | 4.12% |
| 12 | HALOZYME THERAPEUTICS INC | HALO | 255,049 | $10.4M | 4.00% |
| 13 | PERRIGO CO PLC | PRGO | 322,114 | $10.4M | 4.00% |
| 14 | EXELIXIS INC | EXEL | 398,762 | $9.5M | 3.65% |
| 15 | AVADEL PHARMACEUTICALS PLC | G29687103 | 541,926 | $9.2M | 3.53% |
| 16 | ELI LILLY & CO | LLY | 11,040 | $8.6M | 3.31% |
| 17 | AGIOS PHARMACEUTICALS INC | AGIO | 288,580 | $8.4M | 3.25% |
| 18 | CRISPR THERAPEUTICS AG | CRSP | 120,185 | $8.2M | 3.16% |
| 19 | ARCELLX INC | ACLX | 107,000 | $7.4M | 2.87% |
| 20 | INSMED INC | INSM | 227,337 | $6.2M | 2.38% |
| 21 | VIRIDIAN THERAPEUTICS INC | VRDN | 278,638 | $4.9M | 1.88% |
| 22 | LEGEND BIOTECH CORP | LEGN | 79,830 | $4.5M | 1.73% |
| 23 | KYVERNA THERAPEUTICS INC | KYTX | 166,514 | $4.1M | 1.59% |
| 24 | PLIANT THERAPEUTICS INC | PLRX | 194,119 | $2.9M | 1.12% |
| 25 | CABALETTA BIO INC | CABA | 157,964 | $2.7M | 1.04% |